Antiviral Drugs Market Size, Share, Trends by 2035
Over the years, there has been a growing focus on the development of safe and effective novel antiviral therapeutics owing to the rising cases of life-threatening viral diseases

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antiviral Drugs Market, 2022 – 2035”


To get a sample copy of the latest market report, visit


The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:

§  A detailed assessment of the current market landscape of commercially available antiviral drugs. 

§  A detailed assessment of the current market landscape of clinical-stage antiviral drugs.

§  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).

§  A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).

§  A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.

§  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

§  Mechanism of Action

§  Fusion Inhibitors

§  DNA Polymerases

§  Protease Inhibitors

§  Reverse Transcriptase Inhibitors

§  Other Mechanisms


Target Indication

§  Human Immunodeficiency Virus Infection

§  Hepatitis

§  Herpes Simplex Virus Infection

§  Cytomegalovirus Infection\

§  Influenza

§  Coronavirus Infection

§  Other Target Indications


Type of Drug Target

§  Virus Targets

§  Host Targets


Type of Therapy

§  Monotherapy

§  Combination Therapy


Key Geographical Regions 

§  North America

§  Europe

§  Asia-Pacific

§  Latin America


§  Rest of the World 

Key companies covered in the report

§  AbbVie

§  AstraZeneca

§  Bristol-Myers Squibb

§  Genentech

§  Gilead Sciences

§  GlaxoSmithKline (GSK)

§  Johnson & Johnson

§  Merck

§  Novartis

§  Pfizer

§  Roche

§  ViiV Healthcare


For additional details, please visit


You may also be interested in the following titles:

DNA Encoded Libraries

Quantum Computing in Drug Discovery Services Market


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Ben Johnson

+1 (415) 800 3415